QuantLogix ← CTAS scorecard
📅 CTAS Earnings Preview
CTAS
Next report (est.)
01/06/2027
Countdown
71 days
EPS growth YoY
+13.3%
Revenue growth YoY
+10.9%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
10/07/2026 ±1.7% +0.6% over-priced
07/29/2026 ±2.4% +0.8% over-priced
04/07/2026 ±2.5% -0.8% over-priced
01/07/2026 ±1.7% -0.4% over-priced
10/08/2025 ±1.4% -0.2% over-priced
07/28/2025 ±1.5% -1.4% over-priced
04/03/2025 ±2.0% -1.8% over-priced
01/08/2025 ±2.2% +2.1% over-priced
Across these reports, options implied an average ±1.9% move vs an actual average of 1.0% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2027 $1.36 $3.0B $552M
Q4 FY2026 — $2.9B $511M
Q3 FY2026 $1.24 $2.8B $502M
Q2 FY2026 $1.21 $2.8B $495M
Analyst posture
Buy / Strong Buy
15
Hold
11
Sell
1
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 92/100 Full scorecard →
Get alerted before every CTAS report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CTAS before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CTAS (CTAS) reports in 71 days, with the next report estimated for 01/06/2027. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced CTAS's earnings risk. Fundamentals into the print: EPS up 13.3% year-over-year, revenue up 10.9%. QuantLogix's live 5-factor engine currently reads CTAS as a buy at 92/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →